2,851
edits
Nicotinamide Mononucleotide (NMN): Difference between revisions
Nicotinamide Mononucleotide (NMN) (view source)
Revision as of 20:21, 16 December 2023
, 16 December 2023→Reduced NMN (NMNH)
| Line 88: | Line 88: | ||
===Reduced NMN (NMNH)=== | ===Reduced NMN (NMNH)=== | ||
[[Reduced Nicotinamide Mononucleotide (NMNH)]] is a novel, potentially more effective [[NAD+ Precursor|NAD+ precursor]]. | [[Reduced Nicotinamide Mononucleotide (NMNH)]] is a novel, potentially more effective [[NAD+ Precursor|NAD+ precursor]]. | ||
=== NMN-HAP === | |||
NMN-HAP is a hydroxyapatite-based nano-drug delivery system for nicotinamide mononucleotide that showed significantly enhancing NMN bioavailability and replenishing NAD+ levels in mice. NMN-HAP is currently not available as supplement.{{pmid|37862582}} | |||
== Bioavailability of NMN == | == Bioavailability of NMN == | ||